Articles

Efficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentary

Susan G Ball, Durisala Desaiah, Qi Zhang, Michael E Thase, David G S Perahia

Article Type

Review

Published

Major depressive disorder (MDD) is a significant public health concern and challenges health care providers to intervene with appropriate treatment. This review provides evidence that duloxetine 60 mg QD is effective for the treatment of adult patients with MDD in the short- and long-term phases of treatment. Duloxetine 60 mg QD also represents a viable choice of treatment for those patients with painful physical symptoms associated with MDD.

Read more

Novel therapeutic modalities and drug delivery in pancreatic cancer – an ongoing search for improved efficacy

Yuqing Zhang, Kei Satoh and Min Li

Article Type

Case Report

Published

Pancreatic cancer is a challenging disease due to its high rates of resistance to traditional chemotherapy and radiotherapy. There has been little improvement in the prognosis of pancreatic cancer cases in the past decades, highlighting the need for more effective therapeutic approaches. This article summarizes current developments in targeted pancreatic cancer drug delivery, focusing on delivery systems, targets, and therapeutic agents.

Read more

Is ‘GOLD’ standard for the management of COPD in clinical practice?

Barbara P Yawn

Article Type

Case Report

Published

Primary therapy for chronic obstructive pulmonary disease (COPD) is the removal of the toxic agent (in most cases, tobacco smoke). Additional therapy includes bronchodilators. Inhaled corticosteroids and long-acting bronchodilators can be used to prevent and reduce the risk of exacerbations. COPD is a systemic disease and often requires therapy of its protean-associated morbidities from depression to osteoporosis and muscle wasting. Despite pessimism from some, COPD is treatable.

Read more

Metastatic melanoma – a review of current and future drugs

Tiago Rodrigues Velho

Article Type

Case Report

Published

A systematic search of literature was conducted, and studies providing data on the effectiveness of current and/or future drugs used in the treatment of metastatic melanoma were selected for review. This review discusses the advantages and limitations of these agents, evaluating past, current and future clinical trials designed to overcome such limitations.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.